FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 329:977-986 September 30, 1993 Number 14 Next

	Full Text Letters Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Long-term microvascular and neurologic complications cause major morbidity and mortality in patients with insulin-dependent diabetes mellitus (IDDM). We examined whether intensive treatment with the goal of maintaining blood glucose concentrations close to the normal range could decrease the frequency and severity of these complications.

Methods A total of 1441 patients with IDDM -- 726 with no retinopathy at base line (the primary-prevention cohort) and 715 with mild retinopathy (the secondary-intervention cohort) were randomly assigned to intensive therapy administered either with an external insulin pump or by three or more daily insulin injections and guided by frequent blood glucose monitoring or to conventional therapy with one or two daily insulin injections. The patients were followed for a mean of 6.5 years, and the appearance and progression of retinopathy and other complications were assessed regularly.

Results In the primary-prevention cohort, intensive therapy reduced the adjusted mean risk for the development of retinopathy by 76 percent (95 percent confidence interval, 62 to 85 percent), as compared with conventional therapy. In the secondary-intervention cohort, intensive therapy slowed the progression of retinopathy by 54 percent (95 percent confidence interval, 39 to 66 percent) and reduced the development of proliferative or severe nonproliferative retinopathy by 47 percent (95 percent confidence interval, 14 to 67 percent). In the two cohorts combined, intensive therapy reduced the occurrence of microalbuminuria (urinary albumin excretion of 40 mg per 24 hours) by 39 percent (95 percent confidence interval, 21 to 52 percent), that of albuminuria (urinary albumin excretion of 300 mg per 24 hours) by 54 percent (95 percent confidence interval, 19 to 74 percent), and that of clinical neuropathy by 60 percent (95 percent confidence interval, 38 to 74 percent). The chief adverse event associated with intensive therapy was a two-to-threefold increase in severe hypoglycemia.

Conclusions Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.

Source Information

A complete list of the persons and institutions participating in the Diabetes Control and Complications Trial Research Group appears in the Appendix.

Address reprint requests to the DCCT Research Group, Box NDIC/DCCT, Bethesda, MD 20892.

Full Text of this Article

Related Letters:

Causes of Death in Injection-Drug Users
Woody G. E., Metzger D. S.
Extract | Full Text  
N Engl J Med 1993; 329:1661, Nov 25, 1993. Correspondence

Inadvertent Placement of an Advertisement
Merkel P. A., Kassirer J. P.
Extract | Full Text  
N Engl J Med 1993; 329:1661-1662, Nov 25, 1993. Correspondence

The Effect of Intensive Treatment of Diabetes Mellitus
Townsend R. R., Kapoor S. C., Garber A., Gerard D., Nathan D. M., Crofford O. B., Lachin J. M.
Extract | Full Text  
N Engl J Med 1994; 330:641-642, Mar 3, 1994. Correspondence

This article has been cited by other articles:

• The Juvenile Diabetes Research Foundation Continuo, (2008). Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. NEJM 359: 1464-1476 [Abstract] [Full Text]  
• Maeda, S. (2008). Review: Genetics of diabetic nephropathy. Therapeutic Advances in Cardiovascular Disease 2: 363-371 [Abstract]  
• Anaya, J. P., Rivera, J. O., Lawson, K., Garcia, J., Luna, J. Jr., Ortiz, M. (2008). Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm 65: 1841-1845 [Abstract] [Full Text]  
• Odom, J., Williamson, B., Carter, L. (2008). Rosiglitazone and pioglitazone in the treatment of diabetes mellitus. Am J Health Syst Pharm 65: 1846-1850 [Full Text]  
• Perlmuter, L. C., Flanagan, B. P., Shah, P. H., Singh, S. P. (2008). Glycemic Control and Hypoglycemia: Is the loser the winner?. Diabetes Care 31: 2072-2076 [Full Text]  
• Mealey, B. L. (2008). The Interactions Between Physicians and Dentists in Managing the Care of Patients With Diabetes Mellitus. Journal of the American Dental Association 139: 4S-7S [Full Text]  
• Kidambi, S., Patel, S. B. (2008). Diabetes Mellitus: Considerations for Dentistry. Journal of the American Dental Association 139: 8S-18S [Abstract] [Full Text]  
• Gill, G., Gebrekidan, A., English, P., Wile, D., Tesfaye, S. (2008). Diabetic complications and glycaemic control in remote North Africa. QJM 101: 793-798 [Abstract] [Full Text]  
• Huttner, S., Graefe-Mody, E. U., Withopf, B., Ring, A., Dugi, K. A. (2008). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers. J Clin Pharmacol 48: 1171-1178 [Abstract] [Full Text]  
• Musen, G., Jacobson, A. M., Ryan, C. M., Cleary, P. A., Waberski, B. H., Weinger, K., Dahms, W., Bayless, M., Silvers, N., Harth, J., White, N., the Diabetes Control and Complications Trial/Epide, (2008). Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial. Diabetes Care 31: 1933-1938 [Abstract] [Full Text]  
• Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., and the DCCT/EDIC Cohort Study Group, (2008). Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications. Diabetes Care 31: 2006-2012 [Abstract] [Full Text]  
• Maile, L. A., Capps, B. E., Miller, E. C., Aday, A. W., Clemmons, D. R. (2008). Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo. Diabetes 57: 2637-2643 [Abstract] [Full Text]  
• Tan, J., Yang, S., Cai, J., Guo, J., Huang, L., Wu, Z., Chen, J., Liao, L. (2008). Simultaneous Islet and Kidney Transplantation in Seven Patients With Type 1 Diabetes and End-Stage Renal Disease Using a Glucocorticoid-Free Immunosuppressive Regimen With Alemtuzumab Induction. Diabetes 57: 2666-2671 [Abstract] [Full Text]  
• Kottgen, A., Hwang, S.-J., Rampersaud, E., Coresh, J., North, K. E., Pankow, J. S., Meigs, J. B., Florez, J. C., Parsa, A., Levy, D., Boerwinkle, E., Shuldiner, A. R., Fox, C. S., Kao, W.H. L. (2008). TCF7L2 Variants Associate with CKD Progression and Renal Function in Population-Based Cohorts. J. Am. Soc. Nephrol. 19: 1989-1999 [Abstract] [Full Text]  
• de Boer, I. H., Kestenbaum, B., Rue, T. C., Steffes, M. W., Cleary, P. A., Molitch, M. E., Lachin, J. M., Weiss, N. S., Brunzell, J. D., for the Diabetes Control and Complications Trial (, (2008). Insulin Therapy, Hyperglycemia, and Hypertension in Type 1 Diabetes Mellitus. Arch Intern Med 168: 1867-1873 [Abstract] [Full Text]  
• Kern, T. S., Barber, A. J. (2008). Retinal ganglion cells in diabetes. J. Physiol. 586: 4401-4408 [Abstract] [Full Text]  
• Pan, Y., Guo, L. L., Jin, H. M. (2008). Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88: 660-666 [Abstract] [Full Text]  
• Patasi, B., Conway, J. R. (2008). Enhancing diabetes care in family practice: A flow sheet. cfp 54: 1237-1238 [Full Text]  
• Sako, T., Mori, A., Lee, P., Takahashi, T., Izawa, T., Karasawa, S., Furuuchi, M., Azakami, D., Mizukoshi, M., Mizutani, H., Kiyosawa, Y., Arai, T. (2008). Diagnostic significance of serum glycated albumin in diabetic dogs. jvdi 20: 634-638 [Abstract] [Full Text]  
• Halkos, M. E., Puskas, J. D., Lattouf, O. M., Kilgo, P., Kerendi, F., Song, H. K., Guyton, R. A., Thourani, V. H. (2008). Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 136: 631-640 [Abstract] [Full Text]  
• Finucane, M. L., McMullen, C. K. (2008). Making Diabetes Self-management Education Culturally Relevant for Filipino Americans in Hawaii. The Diabetes Educator 34: 841-853 [Abstract] [Full Text]  
• Iqbal, N., Morgan, C., Maksoud, H., Idris, I. (2008). Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes. Ann Clin Biochem 45: 504-507 [Abstract] [Full Text]  
• Nikkanen, T., Timonen, M., Ylitalo, K., Timonen, O., Keinanen-Kiukaanniemi, S., Rajala, U. (2008). Quality of diabetes care among patients managed by teleconsultation. J Telemed Telecare 14: 295-299 [Abstract] [Full Text]  
• Farley, T. F., Mandava, N., Prall, F. R., Carsky, C. (2008). Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photography. Ann Fam Med 6: 428-434 [Abstract] [Full Text]  
• Sherwin, R. S. (2008). Bringing Light to the Dark Side of Insulin: A Journey Across the Blood-Brain Barrier. Diabetes 57: 2259-2268 [Full Text]  
• Kilpatrick, E S (2008). Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J. Clin. Pathol. 61: 977-982 [Abstract] [Full Text]  
• Berg, A H, Sacks, D B (2008). Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony. J. Clin. Pathol. 61: 983-987 [Abstract] [Full Text]  
• Kowluru, R. A., Kanwar, M., Chan, P.-S., Zhang, J. P. (2008). Inhibition of Retinopathy and Retinal Metabolic Abnormalities in Diabetic Rats With AREDS-Based Micronutrients. Arch Ophthalmol 126: 1266-1272 [Abstract] [Full Text]  
• Thiebaud, P., Demand, M., Wolf, S. A., Alipuria, L. L., Ye, Q., Gutierrez, P. R. (2008). Impact of Disease Management on Utilization and Adherence With Drugs and Tests: The case of diabetes treatment in the Florida: A Healthy State (FAHS) program. Diabetes Care 31: 1717-1722 [Abstract] [Full Text]  
• Hall, P. A., Coons, M. J., Vallis, T. M. (2008). Anxious Temperament and Disease Progression at Diagnosis: The Case of Type 2 Diabetes. Psychosom. Med. 70: 837-843 [Abstract] [Full Text]  
• Melamed, M. L., Bauer, C., Hostetter, T. H. (2008). eGFR: Is It Ready for Early Identification of CKD?. CJASN 3: 1569-1572 [Abstract] [Full Text]  
• Khera, P. K., Joiner, C. H., Carruthers, A., Lindsell, C. J., Smith, E. P., Franco, R. S., Holmes, Y. R., Cohen, R. M. (2008). Evidence for Interindividual Heterogeneity in the Glucose Gradient Across the Human Red Blood Cell Membrane and Its Relationship to Hemoglobin Glycation. Diabetes 57: 2445-2452 [Abstract] [Full Text]  
• Kile, M. L., Christiani, D. C. (2008). Environmental Arsenic Exposure and Diabetes. JAMA 300: 845-846 [Full Text]  
• Wilper, A. P., Woolhandler, S., Lasser, K. E., McCormick, D., Bor, D. H., Himmelstein, D. U. (2008). A National Study of Chronic Disease Prevalence and Access to Care in Uninsured U.S. Adults. ANN INTERN MED 149: 170-176 [Abstract] [Full Text]  
• Duke, D. C., Geffken, G. R., Lewin, A. B., Williams, L. B., Storch, E. A., Silverstein, J. H. (2008). Glycemic Control in Youth with Type 1 Diabetes: Family Predictors and Mediators. J Pediatr Psychol 33: 719-727 [Abstract] [Full Text]  
• Goldman, R. E., Sanchez-Hernandez, M., Ross-Degnan, D., Piette, J. D., Trinacty, C. M., Simon, S. R. (2008). Developing an automated speech-recognition telephone diabetes intervention. Int J Qual Health Care 20: 264-270 [Abstract] [Full Text]  
• Fonseca, V. A., Rosenstock, J., Wang, A. C., Truitt, K. E., Jones, M. R. (2008). Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy. Diabetes Care 31: 1479-1484 [Abstract] [Full Text]  
• Kumar, A. F., Gruessner, R. W.G., Seaquist, E. R. (2008). Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism. Diabetes Care 31: 1639-1643 [Abstract] [Full Text]  
• O'Connell, M. A., Gilbertson, H. R., Donath, S. M., Cameron, F. J. (2008). Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy: Impact of glycemic index and prandial bolus type. Diabetes Care 31: 1491-1495 [Abstract] [Full Text]  
• Hietala, K., Forsblom, C., Summanen, P., Groop, P.-H., on behalf of the FinnDiane Study Group, (2008). Heritability of Proliferative Diabetic Retinopathy. Diabetes 57: 2176-2180 [Abstract] [Full Text]  
• Geistanger, A., Arends, S., Berding, C., Hoshino, T., Jeppsson, J.-O., Little, R., Siebelder, C., Weykamp, C., on behalf of the IFCC Working Group on Standardiza, (2008). Statistical Methods for Monitoring the Relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan, and Sweden. Clin. Chem. 54: 1379-1385 [Abstract] [Full Text]  
• Little, R. R., Rohlfing, C. L., Hanson, S., Connolly, S., Higgins, T., Weykamp, C. W., D'Costa, M., Luzzi, V., Owen, W. E., Roberts, W. L. (2008). Effects of Hemoglobin (Hb) E and HbD Traits on Measurements of Glycated Hb (HbA1c) by 23 Methods. Clin. Chem. 54: 1277-1282 [Abstract] [Full Text]  
• Goldberg, R. B., Fonseca, V. A., Truitt, K. E., Jones, M. R. (2008). Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy. Arch Intern Med 168: 1531-1540 [Abstract] [Full Text]  
• Davis, E. M., Christensen, C. M., Nystrom, K. K., Foral, P. A., Destache, C. (2008). Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm 65: 1347-1357 [Abstract] [Full Text]  
• Yoshida, M., Booth, S. L, Meigs, J. B, Saltzman, E., Jacques, P. F (2008). Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am. J. Clin. Nutr. 88: 210-215 [Abstract] [Full Text]  
• Rhee, M. K., Ziemer, D. C., Caudle, J., Kolm, P., Phillips, L. S. (2008). Use of a Uniform Treatment Algorithm Abolishes Racial Disparities in Glycemic Control. The Diabetes Educator 34: 655-663 [Abstract] [Full Text]  
• Ginde, A. A., Pallin, D. J., Camargo, C. A. Jr (2008). Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia. The Diabetes Educator 34: 683-691 [Abstract] [Full Text]  
• Macdonald, D. R, Hanson, A. M, Holland, M. R, Singh, B. M (2008). Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis. Ann Clin Biochem 45: 421-425 [Abstract] [Full Text]  
• Fowler, M. J. (2008). Diabetes Devices. Clin. Diabetes 26: 130-133 [Full Text]  
• Freeman, J. S., Capuzzi, D. M., Rockwell, K. (2008). Leveraging Continuous Glucose Monitoring in the Clinical Management of Adjunctive Pramlintide Therapy. Clin. Diabetes 26: 134-137 [Full Text]  
• Triplitt, C., Alvarez, C. A. (2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr. 21: 177-189 [Abstract] [Full Text]  
• Ramser, K. L., Sprabery, L. R., George, C. M., Hamann, G. L., Vallejo, V. A., Dorko, C. S., Kuhl, D. A. (2008). Physician-Pharmacist Collaboration in the Management of Patients With Diabetes Resistant to Usual Care. Diabetes Spectr. 21: 209-214 [Full Text]  
• Huang, E. S., Zhang, Q., Gandra, N., Chin, M. H., Meltzer, D. O. (2008). The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis. ANN INTERN MED 149: 11-19 [Abstract] [Full Text]  
• Bergenstal, R. M., Johnson, M., Powers, M. A., Wynne, A., Vlajnic, A., Hollander, P., Rendell, M. (2008). Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 31: 1305-1310 [Abstract] [Full Text]  
• Rossetti, P., Porcellati, F., Busciantella Ricci, N., Candeloro, P., Cioli, P., Nair, K. S., Santeusanio, F., Bolli, G. B., Fanelli, C. G. (2008). Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People. Diabetes 57: 1905-1917 [Abstract] [Full Text]  
• Hilliard, M. E., Goeke-Morey, M., Cogen, F. R., Henderson, C., Streisand, R. (2008). Predictors of Diabetes-related Quality of Life after Transitioning to the Insulin Pump. J Pediatr Psychol 0: jsn062v2-jsn062 [Abstract] [Full Text]  
• Dabir, P., Marinic, T. E., Krukovets, I., Stenina, O. I. (2008). Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells. Circ. Res. 102: 1558-1565 [Abstract] [Full Text]  
• Norris, S. L., Kansagara, D., Bougatsos, C., Fu, R. (2008). Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 148: 855-868 [Abstract] [Full Text]  
• Suying Li, , Jiannong Liu, , Gilbertson, D., McBean, M., Dowd, B., Collins, A. (2008). An Instrumental Variable Analysis of the Impact of Practice Guidelines on Improving Quality of Care and Diabetes-Related Outcomes in the Elderly Medicare Population. American Journal of Medical Quality 23: 222-230 [Abstract]  
• Meece, J. (2008). Effect of insulin pen devices on the management of diabetes mellitus. Am J Health Syst Pharm 65: 1076-1082 [Full Text]  
• Phillips, B. E., Cancel, L., Tarbell, J. M., Antonetti, D. A. (2008). Occludin Independently Regulates Permeability under Hydrostatic Pressure and Cell Division in Retinal Pigment Epithelial Cells. IOVS 49: 2568-2576 [Abstract] [Full Text]  
• Wu, M., Chen, Y., Wilson, K., Chirindel, A., Ihnat, M. A., Yu, Y., Boulton, M. E., Szweda, L. I., Ma, J.-X., Lyons, T. J. (2008). Intraretinal Leakage and Oxidation of LDL in Diabetic Retinopathy. IOVS 49: 2679-2685 [Abstract] [Full Text]  
• Helgeson, V. S., Reynolds, K. A., Siminerio, L., Escobar, O., Becker, D. (2008). Parent and Adolescent Distribution of Responsibility for Diabetes Self-care: Links to Health Outcomes. J Pediatr Psychol 33: 497-508 [Abstract] [Full Text]  
• Balagopal, P., Kamalamma, N., Patel, T. G., Misra, R. (2008). A Community-Based Diabetes Prevention and Management Education Program in a Rural Village in India. Diabetes Care 31: 1097-1104 [Abstract] [Full Text]  
• Kaiser, P., Akerboom, T., Molnar, P., Reinauer, H. (2008). Modified HPLC-Electrospray Ionization/Mass Spectrometry Method for HbA1c Based on IFCC Reference Measurement Procedure. Clin. Chem. 54: 1018-1022 [Abstract] [Full Text]  
• O'Kane, M. J, Bunting, B., Copeland, M., Coates, V. E, on behalf of the ESMON study group, (2008). Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 336: 1174-1177 [Abstract] [Full Text]  
• Kuitert, L. (2008). The lung in diabetes - yet another target organ?. Chronic Respiratory Disease 5: 67-68  
• Kaparianos, A, Argyropoulou, E, Sampsonas, F, Karkoulias, K, Tsiamita, M, Spiropoulos, K (2008). Pulmonary complications in diabetes mellitus. Chronic Respiratory Disease 5: 101-108 [Abstract]  
• (2008). Management of Children With Diabetes in the School Setting. The Diabetes Educator 34: 439-443 [Full Text]  
• Marvicsin, D. (2008). School-Age Children With Diabetes: Role of Maternal Self-Efficacy, Environment, and Management Behaviors. The Diabetes Educator 34: 477-483 [Abstract] [Full Text]  
• Zoffmann, V., Harder, I., Kirkevold, M. (2008). A Person-Centered Communication and Reflection Model: Sharing Decision-Making in Chronic Care. Qual Health Res 18: 670-685 [Abstract]  
• Weinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., Tamborlane, W. V. (2008). Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas. Diabetes Care 31: 934-939 [Abstract] [Full Text]  
• Hanberger, L., Samuelsson, U., Lindblad, B., Ludvigsson, J. (2008). A1C in Children and Adolescents With Diabetes in Relation to Certain Clinical Parameters: The Swedish Childhood Diabetes Registry SWEDIABKIDS. Diabetes Care 31: 927-929 [Abstract] [Full Text]  
• Tuerk, P. W., Mueller, M., Egede, L. E. (2008). Estimating Physician Effects on Glycemic Control in the Treatment of Diabetes: Methods, effects sizes, and implications for treatment policy. Diabetes Care 31: 869-873 [Abstract] [Full Text]  
• Rosolowsky, E. T., Ficociello, L. H., Maselli, N. J., Niewczas, M. A., Binns, A. L., Roshan, B., Warram, J. H., Krolewski, A. S. (2008). High-Normal Serum Uric Acid Is Associated with Impaired Glomerular Filtration Rate in Nonproteinuric Patients with Type 1 Diabetes. CJASN 3: 706-713 [Abstract] [Full Text]  
• Feltbower, R. G., Bodansky, H. J., Patterson, C. C., Parslow, R. C., Stephenson, C. R., Reynolds, C., McKinney, P. A. (2008). Acute Complications and Drug Misuse Are Important Causes of Death for Children and Young Adults With Type 1 Diabetes: Results from the Yorkshire Register of Diabetes in Children and Young Adults. Diabetes Care 31: 922-926 [Abstract] [Full Text]  
• Bauer, C., Melamed, M. L., Hostetter, T. H. (2008). Staging of Chronic Kidney Disease: Time for a Course Correction. J. Am. Soc. Nephrol. 19: 844-846 [Abstract] [Full Text]  
• Levin, B. E., Becker, T. C., Eiki, J.-i., Zhang, B. B., Dunn-Meynell, A. A. (2008). Ventromedial Hypothalamic Glucokinase Is an Important Mediator of the Counterregulatory Response to Insulin-Induced Hypoglycemia. Diabetes 57: 1371-1379 [Abstract] [Full Text]  
• Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., Giugliano, D. (2008). Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients. Diabetes 57: 1349-1354 [Abstract] [Full Text]  
• Sanders, N. M., Wilkinson, C. W., Taborsky, G. J. Jr., Al-Noori, S., Daumen, W., Zavosh, A., Figlewicz, D. P. (2008). The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 294: E853-E860 [Abstract] [Full Text]  
• Chan, O., Cheng, H., Herzog, R., Czyzyk, D., Zhu, W., Wang, A., McCrimmon, R. J., Seashore, M. R., Sherwin, R. S. (2008). Increased GABAergic Tone in the Ventromedial Hypothalamus Contributes to Suppression of Counterregulatory Reponses After Antecedent Hypoglycemia. Diabetes 57: 1363-1370 [Abstract] [Full Text]  
• Kruger, D. F. (2008). Exploring the Pharmacotherapeutic Options for Treating Type 2 Diabetes. The Diabetes Educator 34: 60S-65S [Abstract] [Full Text]  
• Trief, P. M., Ellison, R. A. (2008). Mandated Diabetes Registries Will Not Benefit Persons With Diabetes. Arch Intern Med 168: 799-802 [Full Text]  
• Ng, J. S., Bearse, M. A. Jr, Schneck, M. E., Barez, S., Adams, A. J. (2008). Local Diabetic Retinopathy Prediction by Multifocal ERG Delays over 3 Years. IOVS 49: 1622-1628 [Abstract] [Full Text]  
• Kichler, J. C., Foster, C., Opipari-Arrigan, L. (2008). The Relationship between Negative Communication and Body Image Dissatisfaction in Adolescent Females with Type 1 Diabetes Mellitus. J Health Psychol 13: 336-347 [Abstract]  
• Fowler, M. J. (2008). Microvascular and Macrovascular Complications of Diabetes. Clin. Diabetes 26: 77-82 [Full Text]  
• Chalew, S. (2008). Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome? The Hvidoere Study Group on Childhood Diabetes: Response to de Beaufort et al.. Diabetes Care 31: e27-e27 [Full Text]  
• Deeb, L. C. (2008). Diabetes Technology During the Past 30 Years: A Lot of Changes and Mostly for the Better. Diabetes Spectr. 21: 78-83 [Abstract] [Full Text]  
• Bloomgarden, D. K., Freeman, J., DeRobertis, E. (2008). Early Patient and Clinician Experiences with Continuous Glucose Monitoring. Diabetes Spectr. 21: 128-133 [Abstract] [Full Text]  
• Hirsch, I. B. (2008). Piecing the Puzzle Together: ACCORDing to Whom?. J. Clin. Endocrinol. Metab. 93: 1161-1163 [Full Text]  
• Juutilainen, A., Lehto, S., Ronnemaa, T., Pyorala, K., Laakso, M. (2008). Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects. Diabetes Care 31: 714-719 [Abstract] [Full Text]  
• Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., for the DCCT/EDIC Research Group, (2008). Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial--Revisited. Diabetes 57: 995-1001 [Abstract] [Full Text]  
• Toth, C., Rong, L. L., Yang, C., Martinez, J., Song, F., Ramji, N., Brussee, V., Liu, W., Durand, J., Nguyen, M. D., Schmidt, A. M., Zochodne, D. W. (2008). Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy. Diabetes 57: 1002-1017 [Abstract] [Full Text]